Problem statement: Answer the multiple choice question.
Question: Which drug exhibits a 0.233\% hERG inhibition at 1uM?
Constraint: You must select none, one or more options from a, b, c, d, or e without using any additional words.
Options:
a. Cc1ccc2cccc(N=Cc3c(C)[nH]n(-c4ccccc4)c3=O)c2n1
b. Cc1nc2ncnn2c(C)c1CCC(=O)N1CCOCC1
c. COc1ccc(C)cc1NC(=O)CCN1CCN(c2ccccc2F)CC1.Cl
d. C=C(c1ccccc1O)n1ccnc1
e. O=c1[nH]c2cc3c(cc2cc1CN(Cc1ccco1)C(=S)NCC1CCCO1)OCCO3
Answer: b. Cc1nc2ncnn2c(C)c1CCC(=O)N1CCOCC1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_1uM#}{herg_central_at_1uM__units} {herg_central_at_1uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_1uM%}
Answer: {%multiple_choice_result}. {SMILES#}
Cc1nc2ncnn2c(C)c1CCC(=O)N1CCOCC1
Cc1nc2ncnn2c(C)c1CCC(=O)N1CCOCC1
3-(5,7-dimethyl-[1,2,4]triazolo[1,5-a]pyrimidin-6-yl)-1-morpholin-4-ylpropan-1-one